Wise R, Andrews J M, Bedford K A
Antimicrob Agents Chemother. 1978 Oct;14(4):549-52. doi: 10.1128/AAC.14.4.549.
Bay k 4999 and piperacillin, two new substituted ampicillins, were compared with other beta-lactam antibiotics, including carbenicillin, azlocillin, mezlocillin, benzylpenicillin, ampicillin, and cefoxitin, against a wide range of gram-positive and -negative organisms. Bay k 4999 and piperacillin were extremely active against Pseudomonas aeruginosa (50% inhibited by 2 mug/ml), being about 16-fold more active than carbenicillin. Bay k 4999 was the most active drug against Escherichia coli (50% inhibited by 0.5 mug/ml) and Klebsiella spp. (50% inhibited by 2 mug/ml). Piperacillin and Bay k 4999 were equally active against Proteus spp., and piperacillin had high activity against Bacteroides fragilis (50% inhibited by between 1 and 2 mug/ml).
将新型取代氨苄西林Bay k 4999和哌拉西林与其他β-内酰胺类抗生素(包括羧苄西林、阿洛西林、美洛西林、苄青霉素、氨苄西林和头孢西丁)进行比较,以对抗多种革兰氏阳性和阴性菌。Bay k 4999和哌拉西林对铜绿假单胞菌具有极强的活性(2微克/毫升可抑制50%),其活性约为羧苄西林的16倍。Bay k 4999是对大肠杆菌(0.5微克/毫升可抑制50%)和克雷伯菌属(2微克/毫升可抑制50%)活性最强的药物。哌拉西林和Bay k 4999对变形杆菌属的活性相当,哌拉西林对脆弱拟杆菌具有高活性(1至2微克/毫升可抑制50%)。